Lyophilization Services of New England, Inc. (LSNE), D/B/A: PCI Pharma Services

Form 483 issued November 11, 2020 · Bedford, New Hampshire

Investigator
Eales Os
Observations
2
Pages
2
FEI number
3008546445

In short: On November 11, 2020, FDA issued a Form 483 with 2 observations to Lyophilization Services of New England, Inc. (LSNE), D/B/A: PCI Pharma Services in Bedford, New Hampshire (FEI 3008546445). The investigator was Eales Os. Most observations concern facilities & equipment; the most-cited regulation is 21 CFR 211.58 (maintenance).

At a glance

2 of 2 observations on this 483 concern facilities & equipment.

Facilities & equipment2

Most cited: 21 CFR 211.58 (1×) · 211.67 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The GMP non-aseptic manufacturing facility…

  2. 02

    A standard operating procedure used…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Lyophilization Services of New England, Inc. (LSNE), D/B/A: PCI Pharma Services?

FDA listed 2 observations on this Form 483, mostly about facilities & equipment. The most-cited regulation is 21 CFR 211.58 (maintenance). The opening words of each observation are shown on this page.

Who inspected Lyophilization Services of New England, Inc. (LSNE), D/B/A: PCI Pharma Services?

Eales Os is named on this Form 483. Each investigator has a profile showing what they cite most.

When was Lyophilization Services of New England, Inc. (LSNE), D/B/A: PCI Pharma Services inspected by FDA?

This Form 483 is dated November 11, 2020.

How do I get the full Form 483 for Lyophilization Services of New England, Inc. (LSNE), D/B/A: PCI Pharma Services?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free